Canopy Rivers Inc Share Price Toronto S.E.
Equities
CA1380411084
Pharmaceuticals
Sales 2022 | 18.96L 13.8L 12Cr | Sales 2023 | 73.97L 53.84L 45Cr | Capitalization | 1.08Cr 78.28L 65Cr |
---|---|---|---|---|---|
Net income 2022 | -5.2Cr -3.78Cr -315.57Cr | Net income 2023 | -8.5Cr -6.19Cr -515.83Cr | EV / Sales 2022 | -144 x |
Net cash position 2022 | 30Cr 22Cr 1.81TCr | Net Debt 2023 | 4.21Cr 3.07Cr 255.71Cr | EV / Sales 2023 | 7.15 x |
P/E ratio 2022 |
-0.42
x | P/E ratio 2023 |
-0.13
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 84.53% |
Latest transcript on Canopy Rivers Inc
Managers | Title | Age | Since |
---|---|---|---|
Mike Totzke
CEO | Chief Executive Officer | - | 20/22/20 |
Eddie Lucarelli
DFI | Director of Finance/CFO | - | 01/18/01 |
Amanda Rico
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 39 | 30/21/30 | |
Richard Mavrinac
BRD | Director/Board Member | 71 | 17/18/17 |
Chairman | - | 17/18/17 |
1st Jan change | Capi. | |
---|---|---|
+28.89% | 554.75Cr | |
-32.73% | 352.45Cr | |
-1.58% | 302.93Cr | |
-24.27% | 258.62Cr | |
-10.58% | 228.39Cr | |
+49.91% | 187.88Cr | |
+50.00% | 145.94Cr | |
-11.78% | 142.85Cr | |
+43.81% | 142.21Cr |